To assess the dose proportionality of azacitidine pharmacokinetics ( PK ) after single subcutaneous ( SC ) doses of 25-100 mg/m2 , and determine the effect of renal impairment on PK after single and multiple 75 mg/m2 SC azacitidine doses .